close
close
migores1

Rigel Pharmaceuticals: In Search of More Growth (NASDAQ:RIGL)

This article was written by

Biologics profile picture

Biologics is a full-time healthcare investor who developed a passion for biotechnology and life-saving therapies after working in the medical field for years. Its commercial focus is around innovative companies developing breakthrough therapies and/or pharmaceuticals with catalysts for potential acquisitions.

He is the leader of the Compounding Healthcare investment group. Group features include: multiple healthcare model portfolios, a weekly newsletter, a daily watch list, and chat for dialogue and questions. Learn more.

Analyst Disclosure: We have/have an advantageous long position in RIGL, LLY shares either through holding shares, options or other derivatives. I wrote this article myself and it expresses my own opinions. I receive no compensation for this (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Looking for Alpha’s reveal: Past performance is no guarantee of future results. No recommendation or advice is given as to whether any investment is suitable for any particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, a US broker or investment adviser, or an investment bank. Our analysts are third-party authors that include both professional and individual investors who may not be authorized or certified by any institute or regulatory body.

Related Articles

Back to top button